Stockreport

Oramed Receives Positive Feedback From End-of-Phase 2 Oral Insulin CMC Meeting With FDA

Oramed Pharmaceuticals Inc.  (ORMP) 
Last oramed pharmaceuticals inc. earnings: 4/6 04:46 pm Check Earnings Report
US:NASDAQ Investor Relations: oramed.com/investors
PDF NEW YORK, March 19, 2020 /PRNewswire/ -- Oramed Pharmaceuticals Inc. (Nasdaq: ORMP) (TASE: ORMP) (www.oramed.com), a clinical-stage pharmaceutical company focused on the [Read more]